Children suffering from drug resistant tuberculosis raised concern globally : Study based concern

By  ,  Onlymyhealth editorial team
Jun 28, 2016

Children who are affected with disease resistant tuberculosis has important implications for the TB control programme.


Child affected with TB


The study conducted by University of Sheffiela,Imperial college London and World health organization (WHO) produced the data based on innovative modeling and statistical analysis. The study highlighted the global burden of the disease among children all across the globe. The outcome suggested that more than 67 million children were infected by Mycobacterium tuberculosis  with 850,000 developing active disease.


All these children, across the globe are difficult to manage because of the increased adverse effects of the second-line anti-TB drugs and the extended duration of treatment.
It was found that out of these children, approximately two million were found to be infected with multidrug-resistant (MDR) -tuberculosis strains, leading to 25,000 cases of MDR-TB disease requiring expensive and toxic treatment.


This study also revealed the fact that far more drug-resistant TB occurs in children than is diagnosed. If they are not identified as having drug-resistant TB, children are unlikely to receive appropriate and effective treatment.


In later stages of drug resistant TB young children are more prone to develop TB meningitis and disseminated TB. The findings could have implications for approaches to diagnosis, drug susceptibility testing, treatment and preventive therapy in some parts of the world.


Image Source : Getty


Read More : Health News

Is it Helpful Article?YES1063 Views 0 Comment
I have read the Privacy Policy and the Terms and Conditions. I provide my consent for my data to be processed for the purposes as described and receive communications for service related information.
This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK